Kidswell Bio Corporation (4584.T)
JPY 102.0
(-7.27%)
JPY 102.0
(-7.27%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.43 Billion | 2.77 Billion | 1.56 Billion | 996.54 Million | 1.07 Billion |
| Cost of Revenue | 1.39 Billion | 1.25 Billion | 550.35 Million | 119.57 Million | 654 Million |
| Gross Profit | 1.03 Billion | 1.52 Billion | 1.01 Billion | 876.97 Million | 423 Million |
| Operating Expenses | 2.37 Billion | 2.07 Billion | 1.67 Billion | 1.84 Billion | 7.73 Billion |
| Selling, General and Administrative Expenses | 163.96 Million | 182.93 Million | 101.9 Million | 883 Million | 687 Million |
| Research and Development Expenses | 1.45 Billion | 1.21 Billion | 903.06 Million | 963.86 Million | 898 Million |
| Other Expenses | 757.66 Million | -27.78 Million | 30.87 Million | 1.71 Million | - |
| Cost and Expenses | 3.76 Billion | 3.32 Billion | 2.22 Billion | 1.96 Billion | 8.38 Billion |
| Operating Income | -1.33 Billion | -550.92 Million | -651.13 Million | -969.68 Million | -1.16 Billion |
| Interest Expense | 38.78 Million | 34.83 Million | 15.46 Million | 15.68 Million | 5.2 Million |
| Income Tax Expense | 1.55 Million | 1.21 Million | 1.21 Million | 1.78 Million | 2 Million |
| Earnings before Tax | -1.42 Billion | -656.22 Million | -549.65 Million | -999.68 Million | -7.31 Billion |
| Net Income | -1.42 Billion | -657.43 Million | -550.86 Million | -1 Billion | -7.31 Billion |
| Earnings Per Share Basic | -40.23 | -20.77 | -17.86 | -34.79 | -264.64 |
| Earnings Per Share Diluted | -40.23 | -20.77 | -17.86 | -34.79 | -264.64 |
| Weighted Average Shares Outstanding | 35.34 Million | 31.65 Million | 30.85 Million | 28.78 Million | 27.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.34 Million | 31.65 Million | 30.85 Million | 28.78 Million | 27.64 Million |
| Gross Margin | 0.43 | 0.55 | 0.65 | 0.88 | 0.39 |
| EBIT Margin | -0.57 | -0.21 | -0.40 | -0.98 | -1.08 |
| Profit Margin | -0.58 | -0.24 | -0.35 | -1.00 | -6.79 |
| EBITDA | -1.38 Billion | -620.45 Million | -531.89 Million | -982.99 Million | -7.3 Billion |
| Earnings Before Tax Margin | -0.55 | -0.20 | -0.41 | -0.97 | -1.08 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 482.95 Million | 2.43 Billion | 864.49 Million | 984.87 Million | 535.89 Million | 45.97 Million |
| Cost of Revenue | 259.33 Million | 1.39 Billion | 688.04 Million | 351.9 Million | 351.04 Million | 853 Thousand |
| Gross Profit | 223.62 Million | 1.03 Billion | 176.44 Million | 632.96 Million | 184.84 Million | 45.12 Million |
| Operating Expenses | 382.56 Million | 2.37 Billion | 845.02 Million | 580.33 Million | 449.45 Million | 500.17 Million |
| Selling, General and Administrative Expenses | 205.92 Million | - | - | - | - | 187.64 Million |
| Research and Development Expenses | 176.64 Million | - | 645.88 Million | 260.77 Million | 234.15 Million | 312.53 Million |
| Other Expenses | - | -5.74 Million | 3.83 Million | -11.35 Million | -317 Thousand | 2.09 Million |
| Cost and Expenses | 641.9 Million | 3.76 Billion | 1.53 Billion | 932.23 Million | 800.49 Million | 501.02 Million |
| Operating Income | -158.94 Million | -1.33 Billion | -668.57 Million | 52.63 Million | -264.6 Million | -455.04 Million |
| Interest Expense | 11.26 Million | 38.78 Million | 9.88 Million | 8.22 Million | 9.06 Million | 11.6 Million |
| Income Tax Expense | 405 Thousand | 1.55 Million | -1.29 Million | 2.24 Million | 303 Thousand | 302 Thousand |
| Earnings before Tax | -176.28 Million | -1.42 Billion | -675.97 Million | 35.09 Million | -309.32 Million | -470.32 Million |
| Net Income | -176.69 Million | -1.42 Billion | -674.67 Million | 32.85 Million | -309.62 Million | -470.62 Million |
| Earnings Per Share Basic | -4.49 | - | -17.51 | 0.88 | -9.29 | -14.68 |
| Earnings Per Share Diluted | -4.49 | - | -17.51 | 0.88 | -9.29 | -14.68 |
| Weighted Average Shares Outstanding | 39.31 Million | 35.34 Million | 38.53 Million | 37.33 Million | 33.32 Million | 32.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.31 Million | 35.34 Million | 38.53 Million | 37.33 Million | 33.32 Million | 32.06 Million |
| Gross Margin | 0.46 | 0.43 | 0.20 | 0.64 | 0.34 | 0.98 |
| EBIT Margin | -0.33 | - | -0.77 | 0.04 | -0.56 | -9.98 |
| Profit Margin | -0.37 | -0.58 | -0.78 | 0.03 | -0.58 | -10.24 |
| EBITDA | -158.71 Million | - | -666.86 Million | 40.01 Million | -300.25 Million | -458.71 Million |
| Earnings Before Tax Margin | -0.33 | -0.55 | -0.77 | 0.05 | -0.49 | -9.90 |
AS
ACUC
DMB
BSQKZ
CDP
PAAL-B